All News | FDA

Advertising & Promotion

Mar 17, 2022
Jury Recommends Nearly $45 Million in Damages in False Advertising Case
Mar 9, 2022
Sackler Family Settles with Eight States, D.C. Over Opioid Marketing
Mar 3, 2022
OPDP Researchers Detail Studies Planned in 2022
Feb 23, 2022
OPDP Issues First 2022 Warning Letter Over Video Promoting Investigational New Drug
Feb 17, 2022
Seven Senators Urge DOJ to Investigate Sacklers
Feb 15, 2022
Senate Narrowly Confirms Califf as FDA Commissioner
Feb 4, 2022
More States, Tribes Settle Lawsuits Over Opioid Marketing
Jan 28, 2022
OPDP Issues First Untitled Letter of 2022
Jan 21, 2022
Bill To Remove DTC Prescription Drug Advertising Deduction Introduced in US House
Jan 14, 2022
OPDP Reminds Companies in Untitled Letter That Complete Promotions Must Be Submitted

Good Clinical Practice

May 6, 2022
FDA User Fee Bill Would Require Diversity Action Plans for Clinical Trials
Apr 29, 2022
Eight-Year OHRP Review Ends With Determination Letter; Investigator Gets FDA Warning Letter
Apr 18, 2022
FDA Permanently Debars Clinical Investigator, Clinical Study Coordinator for Fabricating Trial Data
Apr 15, 2022
FDA Recommends Race and Ethnicity Diversity Plan for Trials
Apr 13, 2022
Bills Requiring Drug Trial Cost Reporting Introduced
Apr 2, 2022
FDA Issues Three Final Guidances To Aid Cancer Trials
Mar 25, 2022
SACHRP: Research Enterprise Needs To Do More To Protect Non-subjects
Mar 18, 2022
OHRP Issues First Determination Letters Since 2020; Investigator Receives FDA Warning Letter
Mar 17, 2022
OIG: Device Firm’s Cost-Sharing Subsidies for Clinical Study Would Pose Only Minimal Risk of Fraud
Mar 14, 2022
FDA Permanently Debars Two Clinical Trial Site Staff Members

U.S. Food Labeling

Feb 4,2021
Suits Filed Against Chain Stores Allege Improper Labeling of Store-Brand Products
Jan 28,2021
Ninth Circuit Rejects on Preemption Grounds Allegation that Biotin Structure/Function Claim Was Deceptive
Jan 22,2021
Woodcock Becomes Acting FDA Commissioner Following Hahn’s Resignation as Biden Administration Begins
Jan 21,2021
FTC, FDA Move Against Dozens of Supplement Firms Making False COVID-19 Claims
Jan 7,2021
ANPR Issued on USDA’s Oversight of Genetically Engineered Animals
Jan 7,2021
Petition Seeks Dietary Fiber Consideration for Gum Acacia
Jan 7,2021
FDA Sets New Food Labeling Uniform Compliance Date
Jan 7,2021
Supplement Firm Owner Pleads Guilty to Drug Distribution
Jan 7,2021
FDA Warns Retailer About Undeclared Allergens
Dec 23,2020
FDA Finalizes Labeling Guidance on Alternate Name for Potassium Chloride

FDA Regulation & Enforcement

Dec 11, 2024
CDRH Provides Early Alert of Potentially High-Risk Device Recall Under Pilot Program
Dec 10, 2024
Public Citizen Asks FTC To Examine Dr. Oz’s iHerb Social Media Posts
Dec 6, 2024
FDA, FSIS Want Information on Food Date Labeling
Nov 29, 2024
FSIS Sets Jan. 1, 2028, as Next Uniform Compliance Date for New Labeling Regs
Nov 27, 2024
GAO: Attrition Among FDA Investigator Workforce Hampers Agency’s Ability To Meet Inspection Goals
Nov 27, 2024
Appeals Court Upholds Dismissal of Complaint Alleging Fruit Cup Labeling Was False
Nov 25, 2024
Trump Names Dr. Marty Makary To Lead FDA
Nov 20, 2024
Citing Preemption and Ohio Tort Law, Court Dismisses Claims Related to Cervical Disk Device Failure
Nov 20, 2024
QOL Medical, CEO To Pay $47 Million To Resolve False Claims Allegations Stemming From Free Lab Tests
Nov 15, 2024
OPDP Issues Untitled Letter Over Instagram Post

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.